about
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumabHypocalcemia in a Patient with Cancer.Pathophysiology of Bone Remodelling and Current Therapeutic Approaches.Emerging ideas: can erythromycin reduce the risk of aseptic loosening?Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targetsOsteoporosis: now and the futureDenosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysisNew and emerging concepts in the use of denosumab for the treatment of osteoporosis
P2860
Q28727655-7FB912B4-D239-411D-9D89-109FDE4806B0Q30253004-2A6D380E-8048-45F0-9201-44320FF28ABFQ34209614-0F875BC2-149A-4A22-92BE-41F34CC59B0DQ35078775-B4E5FBB2-E015-4A51-A43F-8B2A9B0BB8ECQ35643989-9ACEC404-4294-49A2-A448-F62505218FD0Q36158922-339BBBC0-F9E2-414B-9343-62FD40CF638BQ36564425-11EAAF7B-304D-4F81-B5F0-B785917A3FC8Q57071706-BB3F5A88-DD01-47C4-82DF-536CE1060F9AQ58583955-908ED360-4D03-4D2F-983E-7A8D2DC026A4
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
RANKL inhibition: from mice to men (and women).
@en
type
label
RANKL inhibition: from mice to men (and women).
@en
prefLabel
RANKL inhibition: from mice to men (and women).
@en
P2093
P1476
RANKL inhibition: from mice to men (and women)
@en
P2093
Debra J Zack
Lorraine A Fitzpatrick
Marina Stolina
Paul J Kostenuik
William C Dougall
P304
P356
10.1007/978-0-387-72009-8_18
P407
P577
2007-01-01T00:00:00Z